Development of a metabonomic approach based on LC-ESI-HRMS measurements for profiling of metabolic changes induced by recombinant equine growth hormone in horse urine

Kieken, Fanny; Pinel, Gaud; Antignac, Jean-Philippe; Monteau, Fabrice; Paris, Anne Christelle; Popot, Marie-Agnès; Bonnaire, Yves; Le Bizec, Bruno
August 2009
Analytical & Bioanalytical Chemistry;Aug2009, Vol. 394 Issue 8, p2119
Academic Journal
Despite the worldwide existing regulation banning the use of the recombinant equine growth hormone (reGH) as growth promoter, it is suspected to be used in horseracing to improve performances. Various analytical methods previously developed to screen for its misuse have encountered some limitations in terms of detection timeframes, in particular during the first days following reGH administration. A novel strategy involving the characterization of global metabolomic fingerprints in urine samples of non-treated and reGH-treated horses by liquid chromatography–electrospray–high-resolution mass spectrometry (LC-ESI-HRMS) is described and assessed in this paper in order to develop a new screening tool for growth hormone abuse in horseracing. The strategy involves a limited sample preparation of the urine samples and the use of appropriate software for data processing and analysis. As preliminary work, reproducibility of both sample preparation and mass spectrometry (MS) measurements was evaluated in order to demonstrate the reliability of the method. Application of the developed protocol on two horses demonstrated the suitability of the developed strategy and preliminary results showed significant modifications of the metabolome after treatment with reGH. [Figure not available: see fulltext.]


Related Articles

  • Growth hormone and growth hormone binding protein in human urine. Hattori, Naoki; Shimatsu, Akira; Kato, Yuzuru; Imura, Hiroo // Kidney International;Mar1990, Vol. 37 Issue 3, p951 

    The presence of growth hormone binding protein (GH-BP) in urine was demonstrated in normal subjects. Scatchard analysis showed that an association constant (Ka) and a maximum binding capacity (Bmax) of urinary GH-BP were 2.3 ± 0.8 ⊗ 108 M-1 and 19.2 ± 4.0 ng/mg urinary protein,...

  • Weak Evidence of Thyrotropin Receptors in Primary Cultures of Human Osteoblast-like Cells TSH Receptors and Human Osteoblast-like Cells. Tsai, J. A.; Janson, A.; Bucht, E.; Kindmark, H.; Marcus, C.; Stark, A.; Zemack, H. Rawet; Torring, O. // Calcified Tissue International;May2004, Vol. 74 Issue 5, p486 

    Extra-thyroidal thyrotropin (TSH) receptors (TSHRs) have been demonstrated in several tissues and cells, including human and rat osteosarcoma cell lines. We have explored whether human TSHR (hTSHRs) also are present in primary cultures of human osteoblast-like (hOB) cells. [125 I]TSH binding was...

  • Growth hormone and growth hormone-related mRNA in uremic rats: effect of a growth hormone secretagogue. Krieg, Richard J.; Chan, Winnie; Lin, Kwei-Chi; Kuemmerle, Nancy B.; Veldhuis, Johannes D.; Chan, James M. // Pediatric Nephrology;Aug2002, Vol. 17 Issue 8, p585 

    In experimental animals, the decreased growth during mild uremia is not accompanied by a loss in the capacity of the pituitary gland to secrete growth hormone (GH). With the development of orally administered GH "secretagogues" (GHS), it might be possible to stimulate growth during uremia...

  • p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation. Teixeira, L T; Kiyokawa, H; Peng, X D; Christov, K T; Frohman, L A; Kineman, R D // Oncogene;4/6/2000, Vol. 19 Issue 15, p1875 

    p27Kip1 (p27) controls cell cycle progression by binding to and inhibiting the activity of cyclin dependent kinases. Disruption of the p27 gene in mice (p27-/-) results in increased body growth with a disproportionate enlargement of the spleen, thymus, testis, ovary and pituitary. The increase...

  • Somatropin overdose.  // Reactions Weekly;4/19/2008, Issue 1198, p40 

    The article describes the case of a 40-year-old man who developed pancreatitis after an overdose of somatropin to stimulate muscle growth. After discontinuing the drug, he experienced nausea and acute, severe, upper abdominal pain radiating to his back. He had undergone conservative treatment....

  • Exercise modulation of growth hormone isoforms: current knowledge and future directions for the exercise endocrinologist. Nindl, B. C. // British Journal of Sports Medicine;Jun2007, Vol. 41 Issue 6, p346 

    The article presents information on the effects of exercise on growth hormone (GH) molecular heterogeneity. The GH isoforms have diverse downstream metabolic and anabolic actions in target tissues. Molecular heterogeneity has to be concerned when interpreting the meaning of GH concentrations in...

  • The variability of responses to growth hormone therapy in children with short stature. Savage, Martin O.; Bang, Peter // Indian Journal of Endocrinology & Metabolism;Dec2012 Supplement, Vol. 16, pS178 

    Growth hormone (GH) is widely prescribed for children with short stature across a range of growth disorders. We describe the variability of responses seen in conditions approved for GH therapy. Although responses in different growth disorders are satisfactory, evidence is increasing for an...

  • Derangements of the somatotropic hormone axis in chronic renal failure. Tönshoff, Burkhard; Blum, Werner F.; Mehls, Otto // Kidney International Supplement;Mar1997, Issue 58, pS-106 

    Recent evidence indicates that disturbances of the somatotropic hormone axis play an important pathogenic role for growth retardation and catabolism in children with chronic renal failure (CRF). Whereas the growth hormone (GH) secretion rate in CRF is variable between patients and studies, a...

  • Long-term use of recombinant human growth hormone in children with chronic renal insufficiency. Yadin, Ora; Fine, Richard N. // Kidney International Supplement;Mar1997, Issue 58, pS-114 

    Studies the derangements of the somatotropic hormone axis in chronic renal failure (CRF) by researchers from Germany. Investigation of the factors that contribute to the development of growth retardation and catabolism in children with CRF; Evidence showing that disturbances of the somatotropic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics